Ensysce Biosciences, Inc. - Common Stock
Ensysce Biosciences, Inc. - Common Stock
Share · US2936024056 · ENSC (XNAS)
Overview Financial Indicators
2,07 USD
-5,05 % -0,11 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
11.06.2025 23:56

Current Prices from Ensysce Biosciences, Inc. - Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
ENSC
USD
11.06.2025 23:56
2,07 USD
2,03 USD
+1,97 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -10,00 % -5,05 % -54,41 % -69,60 % -74,90 % -99,99 %

Company Profile for Ensysce Biosciences, Inc. - Common Stock Share

Ensysce Biosciences, Inc., a clinical-stage pharmaceutical company, engages in developing various prescription drugs for severe pain relief in opioid addiction, misuse, abuse, and overdose in the United States. It develops products using Trypsin Activated Abuse Protection platform, an abuse-resistant opioid prodrug technology; and Multi-Pill Abuse Resistance platform, an over-dose protection opioid prodrug technology. The company is developing PF614, a TAAP prodrug candidate of oxycodone, which is in Phase II clinical trial for the treatment of acute or chronic pain; and PF614-MPAR, a combination product of PF614 and nafamostat that is in Phase I clinical trial for overdose protection against excessive oral ingestion, as well as an oral and inhalation drug product of nafamostat for use against coronaviral infections and other pulmonary diseases, such as cystic fibrosis. It is also developing PF329, an extended-release prodrug of hydromorphone that is similar to PF614; PF8001 and PF8026 are extended and immediate-release prodrugs of amphetamine for ADHD medication abuse; and PF26810, an extended-release prodrug of methadone for opioid use disorder. The company is based in La Jolla, California.

Company Data

Name Ensysce Biosciences, Inc. - Common Stock
Company Ensysce Biosciences, Inc.
Symbol ENSC
Website https://www.ensysce.com
Primary Exchange XNAS NASDAQ
ISIN US2936024056
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Dr. D. Lynn Kirkpatrick Ph.D.
Country United States of America
Currency USD
Employees 0,0 T
Address 7946 Ivanhoe Avenue, 92037 La Jolla
IPO Date 2018-03-14

Stock Splits

Date Split
06.12.2024 1:15

ID Changes

Date From To
16.09.2018 LACQU ENSC

Ticker Symbols

Name Symbol
NASDAQ ENSC

More Shares

Investors who Ensysce Biosciences, Inc. - Common Stock hold also have the following shares in their portfolio:
DZ BANK CLN E.9384
DZ BANK CLN E.9384 Bond
GENTING HONG KONG
GENTING HONG KONG Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025